These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20574028)

  • 21. Mechanisms of retinal ganglion cell injury in aging and glaucoma.
    Chrysostomou V; Trounce IA; Crowston JG
    Ophthalmic Res; 2010; 44(3):173-8. PubMed ID: 20829641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
    Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection.
    Cone FE; Gelman SE; Son JL; Pease ME; Quigley HA
    Exp Eye Res; 2010 Sep; 91(3):415-24. PubMed ID: 20599961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat.
    Chidlow G; Holman MC; Wood JP; Casson RJ
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1483-97. PubMed ID: 19875659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced Cerebrospinal Fluid Inflow to the Optic Nerve in Glaucoma.
    Mathieu E; Gupta N; Paczka-Giorgi LA; Zhou X; Ahari A; Lani R; Hanna J; Yücel YH
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5876-5884. PubMed ID: 30543343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms.
    Yang Z; Quigley HA; Pease ME; Yang Y; Qian J; Valenta D; Zack DJ
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5539-48. PubMed ID: 18055803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse model of sustained elevation in intraocular pressure produced by episcleral vein occlusion.
    Ruiz-Ederra J; Verkman AS
    Exp Eye Res; 2006 May; 82(5):879-84. PubMed ID: 16310189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic retinal ganglion cell death in the DBA/2 mouse model of glaucoma.
    Reichstein D; Ren L; Filippopoulos T; Mittag T; Danias J
    Exp Eye Res; 2007 Jan; 84(1):13-21. PubMed ID: 17074320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon?
    Morquette JB; Di Polo A
    J Neuroophthalmol; 2008 Jun; 28(2):144-54. PubMed ID: 18562848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
    Hare WA; WoldeMussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2640-51. PubMed ID: 15277487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of retinal function in aged DBA/2J mice - New insights into retinal neurodegeneration.
    Heiduschka P; Julien S; Schuettauf F; Schnichels S
    Exp Eye Res; 2010 Nov; 91(5):779-83. PubMed ID: 20832401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice.
    Quigley HA; Cone FE; Gelman SE; Yang Z; Son JL; Oglesby EN; Pease ME; Zack DJ
    Exp Eye Res; 2011 Apr; 92(4):299-305. PubMed ID: 21272576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.
    McKinnon SJ; Lehman DM; Kerrigan-Baumrind LA; Merges CA; Pease ME; Kerrigan DF; Ransom NL; Tahzib NG; Reitsamer HA; Levkovitch-Verbin H; Quigley HA; Zack DJ
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1077-87. PubMed ID: 11923249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma.
    Zhou X; Li F; Ge J; Sarkisian SR; Tomita H; Zaharia A; Chodosh J; Cao W
    Dev Neurobiol; 2007 Apr; 67(5):603-16. PubMed ID: 17443811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence Supporting an Association Between Expression of Major Histocompatibility Complex II by Microglia and Optic Nerve Degeneration During Experimental Glaucoma.
    Chidlow G; Ebneter A; Wood JP; Casson RJ
    J Glaucoma; 2016 Aug; 25(8):681-91. PubMed ID: 27253969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabotropic glutamate receptors are differentially regulated under elevated intraocular pressure.
    Dyka FM; May CA; Enz R
    J Neurochem; 2004 Jul; 90(1):190-202. PubMed ID: 15198678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.
    John SW; Smith RS; Savinova OV; Hawes NL; Chang B; Turnbull D; Davisson M; Roderick TH; Heckenlively JR
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):951-62. PubMed ID: 9579474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. During glaucoma, alpha2-macroglobulin accumulates in aqueous humor and binds to nerve growth factor, neutralizing neuroprotection.
    Bai Y; Sivori D; Woo SB; Neet KE; Lerner SF; Saragovi HU
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5260-5. PubMed ID: 21642630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys.
    Hayreh SS; Pe'er J; Zimmerman MB
    J Glaucoma; 1999 Feb; 8(1):56-71. PubMed ID: 10084276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.